Envveno Medical Corporation (NVNO)

Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Selling, General, and Administrative	25.66% 2.451	3.297	2.551	2.60	3.202
Depreciation and Amortization	0.00% 0.055	0.055	0.056	0.055	0.054
Operating Income/Loss	12.34% -5.503	-6.278	-5.349	-6.814	-6.797
Nonoperating Income/Loss	18.76% 0.511	0.629	0.348	0.34	0.405
Income/Loss From Continuing Operations Before Tax	11.63% -4.992	-5.649	-5.001	-6.474	-6.392
Income/Loss From Continuing Operations After Tax	11.63% -4.992	-5.649	-5.001	-6.474	-6.392
Net Income/Loss	11.63% -4.992	-5.649	-5.001	-6.474	-6.392
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,401% 16.06	1.07	11.23	11.23	11.23
Diluted Average Shares	1,401% 16.06	1.07	11.23	11.23	-
Basic Earnings Per Share	3.12% -0.31	-0.32	-0.45	-0.58	-0.57
Diluted Earnings Per Share	3.12% -0.31	-0.32	-0.45	-0.58	-0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-